Literature DB >> 17564994

Methicillin-resistant Staphylococcus aureus infection and colonization among hospitalized prisoners.

Marc-Oliver Wright1, Jon P Furuno, Richard A Venezia, Jennifer K Johnson, Harold C Standiford, Joan N Hebden, Judith Hill, David M Hartley, Anthony D Harris, Eli N Perencevich.   

Abstract

We assessed methicillin-resistant Staphylococcus aureus (MRSA) infection and colonization in hospitalized prisoners. Of 434 admission surveillance cultures, 58 (13%) were positive for MRSA. The sensitivity of admission surveillance cultures of samples from the anterior nares was 72% and increased to 84% when the calculation included cultures of wound samples. Hospitalized prisoners are at high risk for MRSA infection and colonization, and surveillance should include cultures of nares and wound samples.

Entities:  

Mesh:

Year:  2007        PMID: 17564994     DOI: 10.1086/518461

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  10 in total

Review 1.  Prevention of Recurrent Staphylococcal Skin Infections.

Authors:  C Buddy Creech; Duha N Al-Zubeidi; Stephanie A Fritz
Journal:  Infect Dis Clin North Am       Date:  2015-09       Impact factor: 5.982

2.  Long-term follow-up of methicillin-resistant Staphylococcus aureus molecular epidemiology after emergence of clone USA300 in San Francisco jail populations.

Authors:  Pierre Tattevin; Binh An Diep; Michael Jula; Françoise Perdreau-Remington
Journal:  J Clin Microbiol       Date:  2008-10-15       Impact factor: 5.948

3.  Hand and nasal carriage of discordant Staphylococcus aureus isolates among urban jail detainees.

Authors:  Michael Z David; Jane D Siegel; Janet Henderson; Greg Leos; Kaming Lo; Jerry Iwuora; Alexis R Taylor; Diana L Zychowski; Esmaeil Porsa; Susan Boyle-Vavra; Robert S Daum
Journal:  J Clin Microbiol       Date:  2014-06-23       Impact factor: 5.948

Review 4.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 5.  Prevention Strategies for Recurrent Community-Associated Staphylococcus aureus Skin and Soft Tissue Infections.

Authors:  J Chase McNeil; Stephanie A Fritz
Journal:  Curr Infect Dis Rep       Date:  2019-03-11       Impact factor: 3.725

6.  Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility.

Authors:  Jon P Furuno; Joan N Hebden; Harold C Standiford; Eli N Perencevich; Ram R Miller; Anita C Moore; Sandra M Strauss; Anthony D Harris
Journal:  Am J Infect Control       Date:  2008-09       Impact factor: 2.918

7.  Predominance of methicillin-resistant Staphylococcus aureus among pathogens causing skin and soft tissue infections in a large urban jail: risk factors and recurrence rates.

Authors:  Michael Z David; Connie Mennella; Mohamed Mansour; Susan Boyle-Vavra; Robert S Daum
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

8.  Prevalence, risk factors, and molecular epidemiology of methicillin-resistant Staphylococcus aureus among newly arrested men in Baltimore, Maryland.

Authors:  Jason E Farley; Tracy Ross; Paul Stamper; Sharon Baucom; Elaine Larson; Karen C Carroll
Journal:  Am J Infect Control       Date:  2008-10-03       Impact factor: 2.918

9.  Comparison of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay to culture by use of BBL CHROMagar MRSA for detection of MRSA in nasal surveillance cultures from an at-risk community population.

Authors:  Jason E Farley; Paul D Stamper; Tracy Ross; Mian Cai; Sharon Speser; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

10.  Prediction of methicillin-resistant Staphylococcus aureus involvement in disease sites by concomitant nasal sampling.

Authors:  Ari Robicsek; Mira Suseno; Jennifer L Beaumont; Richard B Thomson; Lance R Peterson
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.